gohiam.com
Edit

MIG AG

https://www.mig.ag
Last activity: 07.07.2026
Active
Invests in categories: HealthTechIndustrySaaSTechnologyHardwareIndustrialAIDeepTechAudioManufacturing
MIG Verwaltungs AG is shaping the future by investing in young founders and enterprises with potentials. We support them with venture capital. Inform yourself here.
Portfolio
44
Persons
15
Mentions
26
Employees: 1-10
Investment Type: Venture Capital

Portfolio 44

DateNameWebsiteTotal RaisedLocation
07.07.2026Luffy AIluffy.ai$10.87MUnited Kin...
20.11.2025NcodiNncodin.com$22.51MFrance
09.09.2025AMSilk Gmb...amsilk.com$162.18MGermany
24.07.2025ASTRA Ther...astratherapeutics.com$9.87MSwitzerlan...
22.06.2023Look Uplookupspace.com$15.39MFrance, Oc...
30.03.2022Innaterainnatera.com$43.35MNetherland...
30.03.2022Inboltinbolt.fr--
30.03.2022Creative B...creativeballoons.de$18.25MGermany, B...
30.03.2022Mimimimi.io$25MGermany, B...
30.03.2022NeraCare G...melagenix.info--
Show more

Persons 15

DateFirst NameLast NameTitleLinkedInLocation
-SorenHeinPartnerlinkedin.c...-
-MichaelMotschmannVorstandlinkedin.c...-
-Holger Cle...Hinz, CEFAVice Chair...linkedin.c...-
-JürgenKoschVorstand /...linkedin.c...-
-GiuliettaWalderdorf...Working St...linkedin.c...-
-LovisFuhrmannInvestment...linkedin.c...-
-FrederickMichnaPrincipallinkedin.c...-
-OliverKahlPrincipallinkedin.c...-
-AndreasKastenbaue...-linkedin.c...-
-MatthiasGuthVenture Pa...linkedin.c...-
Show more

Mentions in press and media 26

DateTitleDescription
09.07.2026Luffy AI Secures £8.1M to Scale Adaptive Industrial IntelligenceLuffy AI, a cutting-edge UK firm, has secured £8.1 million in Series A funding. BGF led this significant investment round. The company specializes in neuroplastic AI, delivering real-time adaptive control for complex industrial systems. Thi...
07.07.2026Luffy secures £8.1M to scale real-time adaptive control technologyLuffy AI, a UK-based startup developing AI for real-time adaptive control in industrial systems, has raised £8.1 million in a Series A funding round. The investment was led by BGF, with participation from MIG Capital AG through its MIG Fond...
24.11.2025NcodiN Raises €16M for Tiny Lasers to Supercharge AI ChipsNcodiN, a French deeptech startup, secured €16M in seed funding. They're developing tiny lasers for AI chips. These lasers aim to boost speed and energy efficiency. The tech could revolutionize AI hardware. **NcodiN Secures €16M to Develop ...
20.11.2025€16 million investment boosts NcodiN’s development of “world’s smallest laser” for AI chipsParis-based NcodiN, a DeepTech startup innovating AI hardware infrastructure, has raised €16 million in Seed funding to enable scalable, energy-efficient computing through its proof-of-concept nanolasers. The round was led by German VC firm...
20.11.2025NcodiN secures €16M seed investment led by MIG CapitalNcodiN, a French deeptech startup, has secured a €16 million seed investment led by MIG Capital AG through its MIG Fonds 17 and 18. The round also includes participation from Maverick Silicon, PhotonVentures, and Verve Ventures, along with ...
15.09.2025AMSilk Secures €52M to Unleash Industrial Scale Bio-Silk RevolutionAMSilk, a leading innovator in biotech-derived materials, has secured a substantial €52 million in new funding. This significant capital infusion propels the company's ambitious strategy to drastically scale its industrial production of adv...
09.09.2025AMSilk Raises €52M in FundingAMSilk, a Neuried, Germany-based company developing advanced biomaterials made from silk-based proteins, raised €52M in funding. The round was led by ATHOS (AT Newtec), with participation from existing investors MIG Capital and Novo Holding...
25.07.2025ASTRA Therapeutics Secures €8.3 Million Seed Funding, Revolutionizing Animal Health ParasiticidesASTRA Therapeutics, a Swiss biotech innovator, recently secured €8.3 million in seed funding. This significant capital influx fuels its vital mission: pioneering precision parasiticides for animal health. ASTRA's unique ParaX platform engin...
25.07.2025Frisches Kapital für die Parasitenbekämpfung Das 2022 gegründete Biotech-Startup ASTRA Therapeutics entwickelt neuartige Parasitenwirkstoffe, sogenannte Parasitizide. Zur Anwendung kommen sollen die Wirkstoffe dereinst beispielsweise in der Veterinärmedizin, wo Parasiten durch Hemmun...
24.07.2025Swiss BioTech platform ASTRA Therapeutics raises €8.3 million to advance precision Parasiticides for animal healthVilligen-based ASTRA Therapeutics, a BioTech startup designing drugs against eukaryotic pathogens based on its proprietary platform, announced today they have raised a Seed funding round of €8.3 million. The round was led by VC firm MIG Cap...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In